We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.74B
1-Year Est. Return 18.12%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+18.12%
3 Year Est. Return
+65.12%
5 Year Est. Return
+53.27%
10 Year Est. Return
+210.2%
AUM
$255M
AUM Growth
+$17.4M
Cap. Flow
+$3.23M
Cap. Flow %
1.27%
Top 10 Hldgs %
40.98%
Holding
173
New
9
Increased
70
Reduced
65
Closed
7

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.37M
2
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$874K
3
SLB icon
SLB Ltd
SLB
+$547K
4
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$522K
5
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$518K

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$639K
2
CVX icon
Chevron
CVX
+$538K
3
GSK icon
GSK
GSK
+$425K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$359K
5
TSM icon
TSMC
TSM
+$339K

Sector Composition

Rank Sector Weight
1 Consumer Staples 12%
2 Technology 10.83%
3 Financials 9.85%
4 Healthcare 7.55%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTI icon
151
British American Tobacco
BTI
$128B
$242K 0.1%
3,619
– –
HDV
152
iShares Core High Dividend ETF
HDV
$14.9B
$242K 0.1%
13,410
+100
+0.8% +$1.75K
ROL icon
153
Rollins
ROL
$18.2B
$231K 0.09%
11,165
+581
+5% +$11.9K
MAR icon
154
Marriott International
MAR
$92.3B
$226K 0.09%
+1,663
New +$204K
RF icon
155
Regions Financial
RF
$26.8B
$225K 0.09%
13,005
+1,505
+13% +$24.1K
ROIC
156
DELISTED
Retail Opportunity Investments Corp.
ROIC
$223K 0.09%
11,173
+104
+0.9% +$2K
YUM icon
157
Yum! Brands
YUM
$41.1B
$219K 0.09%
2,689
-66
-2% -$5.22K
RY icon
158
Royal Bank of Canada
RY
$293B
$218K 0.09%
2,668
– –
AFL icon
159
Aflac
AFL
$62.6B
$217K 0.09%
+4,938
New +$211K
AIA icon
160
iShares Asia 50 ETF
AIA
$4.73B
$215K 0.08%
+3,255
New +$211K
BHP icon
161
BHP
BHP
$230B
$213K 0.08%
5,192
-921
-15% -$34.7K
SLV icon
162
iShares Silver Trust
SLV
$30.7B
$211K 0.08%
13,199
– –
MON
163
DELISTED
Monsanto Co
MON
$210K 0.08%
1,796
– –
CLX icon
164
Clorox
CLX
$12.7B
$201K 0.08%
+1,350
New +$184K
STRM
165
DELISTED
Streamline Health Solutions
STRM
$108K 0.04%
4,267
– –
QTNT
166
DELISTED
Quotient Limited Ordinary Shares
QTNT
$106K 0.04%
538
– –
ABEV icon
167
Ambev
ABEV
$46.4B
– –
-10,735
Closed -$71K
ADM icon
168
Archer Daniels Midland
ADM
$36.9B
– –
-5,753
Closed -$245K
AMLP icon
169
Alerian MLP ETF
AMLP
$12.8B
– –
-2,368
Closed -$133K
BF.B icon
170
Brown-Forman Class B
BF.B
$13.1B
– –
-6,641
Closed -$231K
ETN icon
171
Eaton
ETN
$174B
– –
-2,840
Closed -$218K
EYPT icon
172
EyePoint Inc
EYPT
$1.2B
– –
-1,778
Closed -$21K
CELG
173
DELISTED
Celgene Corp
CELG
– –
-1,781
Closed -$260K
3 4 5 6
7

Similar funds

SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Nicholas Hoffman & Company's Q4 2017 Portfolio in Review

As of Q4 2017, Nicholas Hoffman & Company held 173 positions worth $255M, up 7.3% from $237M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Nicholas Hoffman & Company's Q4 2017 filing shows 9 new, 70 increased, 65 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K. The largest sale was Walmart Inc, an estimated $639K.

By sector, the portfolio is most concentrated in Consumer Staples at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.

  • Nicholas Hoffman & Company's largest Q4 2017 buy was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K.
  • Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $2.37M increase.
  • Nicholas Hoffman & Company's biggest Q4 2017 reduction was Walmart Inc, cutting an estimated $639K.
  • Nicholas Hoffman & Company fully exited Celgene Corp in Q4 2017, selling an estimated $260K.
  • Nicholas Hoffman & Company's ten largest holdings make up 41% of its $255M portfolio in Q4 2017.
  • Nicholas Hoffman & Company opened 9 new positions and closed 7 in Q4 2017.
  • Nicholas Hoffman & Company's portfolio value rose 7.3% quarter-over-quarter to $255M.

Based on Nicholas Hoffman & Company's 13F filing for Q4 2017, filed 9 Feb 2018.